Silence Therapeutics plc Cash Flows From Used In Operating Activities
Silence Therapeutics plc (SLN) reported Cash Flows From Used In Operating Activities of -GBP 39.35 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2024-03-13
| Period end | Cash Flows From Used In Operating Activities 12 month |
|---|---|
| 2023-12-31 | -39.35M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | -45.46M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 6.81M GBP 20-F · filed 2024-03-13 |
| 2020-12-31 | -10.78M GBP 20-F · filed 2023-03-15 |
| 2019-12-31 | 1.73M GBP 20-F · filed 2022-03-17 |
| 2018-12-31 | -16.76M GBP 20-F/A · filed 2021-04-29 |